NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · page 18 of 27
The slide notes 'n.s.' (not statistically significant) for all metrics. The footer defines SVC and Survival calculation methodology.
Pitch deck · traction · show_traction · balanced density
Slide locked Sign in to view
Slide schematic 4/4
diagram 1/1 source-note 1/1 table 1/1 title 1/1
Components 4
timeline source-note data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.